Dana Pizzuti Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 months, 2 weeks ago
Dana Pizzuti has an estimated net worth of at least $10.5 million*, as of Oct. 1, 2025. They own 66,837 shares of CRNX stock. They have sold 178,891 shares of CRNX stock since 2021, for an estimated $6.5 million.
Dana Pizzuti $CRNX SEC Form 4 Insider Trading
Dana Pizzuti has filed a total of 21 insider trades in $CRNX since 2021. Their most recent trade was a sale of 5,000 shares, made on Dec 01, 2025. Their largest trade was a sale of 30,000 shares, made on Aug 22, 2025. We estimate that they now own 66,837 shares of $CRNX, worth an estimated $4.1 million.
Insider Trading at $CRNX
There have been a total of 126 insider trades reported at $CRNX since 2021, with 1.4 million shares purchased and 1.5 million shares sold. The most active insider traders in $CRNX stock have been Stephen F. Betz, Dana Pizzuti, and Richard Scott Struthers. The most recent trade was a sale of 5,000 shares reported by Dana Pizzuti (Chief Med and Dev Officer), made on Dec 01, 2025.
History of Insider Stock Trades by Dana Pizzuti
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CRNX
|
Sale | 5,000 | Dec 01, 2025 | Dec. 3, 2025, 5:28 p.m. |
|
CRNX
|
Sale | 100 | Nov 03, 2025 | Nov. 5, 2025, 6 p.m. |
|
CRNX
|
Sale | 4,900 | Nov 03, 2025 | Nov. 5, 2025, 6 p.m. |
|
CRNX
|
Sale | 5,000 | Oct 01, 2025 | Oct. 3, 2025, 4:41 p.m. |
|
CRNX
|
Sale | 5,000 | Sep 02, 2025 | Sept. 4, 2025, 4:30 p.m. |
|
CRNX
|
Sale | 30,000 | Aug 22, 2025 | Aug. 26, 2025, 4:30 p.m. |
|
CRNX
|
Sale | 6,492 | Aug 20, 2025 | Aug. 21, 2025, 4:30 p.m. |
|
CRNX
|
Sale | 2,388 | Mar 19, 2025 | March 21, 2025, 6:34 p.m. |
|
CRNX
|
Sale | 127 | Mar 19, 2025 | March 21, 2025, 6:34 p.m. |
|
CRNX
|
Sale | 5,000 | Feb 03, 2025 | Feb. 5, 2025, 5:30 p.m. |
|
CRNX
|
Sale | 15,000 | Jan 03, 2025 | Jan. 7, 2025, 5:30 p.m. |
|
CRNX
|
Sale | 14,375 | Oct 03, 2024 | Oct. 7, 2024, 7:55 a.m. |
|
CRNX
|
Sale | 14,375 | Jul 03, 2024 | July 5, 2024, 4:30 p.m. |
|
CRNX
|
Sale | 9,500 | Jun 24, 2024 | June 25, 2024, 5:03 p.m. |
|
CRNX
|
Sale | 14,375 | Apr 15, 2024 | April 17, 2024, 4:36 p.m. |
|
CRNX
|
Sale | 4,375 | Mar 20, 2024 | March 22, 2024, 4:52 p.m. |
|
CRNX
|
Sale | 10,000 | Mar 20, 2024 | March 22, 2024, 4:52 p.m. |
|
CRNX
|
Sale | 714 | Mar 20, 2024 | March 22, 2024, 4:52 p.m. |
|
CRNX
|
Sale | 14,375 | Jan 03, 2024 | Jan. 4, 2024, 5:45 p.m. |
|
CRNX
|
Sale | 9,583 | Dec 21, 2023 | Dec. 22, 2023, 7:45 p.m. |
|
CRNX
|
Sale | 8,212 | Apr 05, 2023 | April 5, 2023, 7:12 p.m. |
$CRNX Executives and Stock Owners with Insider Trades
-
Stephen F. Betz, Chief Scientific Officer
-
Dana Pizzuti, Chief Med and Dev Officer
-
Richard Scott Struthers, President & CEO
-
Jeff E. Knight, Chief Operating Officer
-
Marc Wilson, CFO
-
Ajay Madan, Chief Development Officer
-
Alan Seth Krasner, Chief Medical Officer
-
James Hassard, Chief Commercial Officer
-
Dana Pizzuti, Chief Development Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.